BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 31320595)

  • 1. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
    Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
    Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Hepatitis B Virus Integrations Identified in Hepatocellular Carcinoma Genomes.
    Mathkar PP; Chen X; Sulovari A; Li D
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
    Tu H; Gao HF; Ma GH; Liu Y
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics.
    Lee WY; Bachtiar M; Choo CCS; Lee CG
    Biol Rev Camb Philos Soc; 2019 Apr; 94(2):353-367. PubMed ID: 30105774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma.
    Huang HP; Tsuei DJ; Wang KJ; Chen YL; Ni YH; Jeng YM; Chen HL; Hsu HY; Chang MH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1206-14. PubMed ID: 16048568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y; Minami M; Daimon Y; Okanoue T
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of HBV Genomes Integrated into the Genomes of Human Hepatoma PLC/PRF/5 Cells by HBV Sequence Capture-Based Next-Generation Sequencing.
    Ishii T; Tamura A; Shibata T; Kuroda K; Kanda T; Sugiyama M; Mizokami M; Moriyama M
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32570699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
    Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
    BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.
    Matsuzaki Y; Chiba T; Hadama T; Asaoka H; Doy M; Shoda J; Tanaka N; Kinoshita M
    Cancer Lett; 1997 Oct; 119(1):53-61. PubMed ID: 18372522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral integration drives multifocal HCC during the occult HBV infection.
    Chen XP; Long X; Jia WL; Wu HJ; Zhao J; Liang HF; Laurence A; Zhu J; Dong D; Chen Y; Lin L; Xia YD; Li WY; Li GB; Zhao ZK; Wu K; Hou Y; Yu JJ; Xiao W; Wang GP; Zhu PC; Chen W; Bai MZ; Jian YX; Kristiansen K; Chen Q
    J Exp Clin Cancer Res; 2019 Jun; 38(1):261. PubMed ID: 31200735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
    Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
    World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
    Freitas N; Lukash T; Gunewardena S; Chappell B; Slagle BL; Gudima SO
    J Virol; 2018 May; 92(10):. PubMed ID: 29491161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer.
    Chen W; Zhang K; Dong P; Fanning G; Tao C; Zhang H; Guo S; Wang Z; Hong Y; Yang X; Lai S; Ding H; Zhao H; Zeng C; Protzer U; Zhang D
    Hepatol Int; 2020 May; 14(3):326-337. PubMed ID: 32100258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of intrahepatic hepatitis B virus DNA integration in patients developing hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
    Jang JW; Kim JS; Kim HS; Tak KY; Nam H; Sung PS; Bae SH; Choi JY; Yoon SK; Roberts LR
    Clin Mol Hepatol; 2021 Jan; 27(1):207-218. PubMed ID: 33317255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
    Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
    J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.
    Saitta C; Tripodi G; Barbera A; Bertuccio A; Smedile A; Ciancio A; Raffa G; Sangiovanni A; Navarra G; Raimondo G; Pollicino T
    Liver Int; 2015 Oct; 35(10):2311-7. PubMed ID: 25677098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.